FDA issued a Warning Letter to Haw Par Healthcare Limited on 8/19/2019 as a result of this inspection.
483 Haw Par Healthcare Mar 2019
483 Haw Par Healthcare Mar 2019
Justin Boyd FDA$119.00 - Available NowFDA investigators audited the Haw Par Healthcare - Singapore, Singapore facility and issued inspectional observations (via FDA 483) on 01 Mar 2019.
Product details
- Category: Human Drugs
- Inspection end: 01 Mar 2019
- Location: Singapore, Singapore
- FEI: 3001432470
